Steroid Hormone Receptors and Regulators
Nuclear hormone receptors are key targets for drug development as many are implicated in diabetes and other endocrine disorders as well as cancer. These molecules are ligand-dependent transcription factors that regulate gene expression in response to a wide range of developmental, physiological, and environmental cues. R&D Systems offers the most complete selection of highly specific monoclonal antibodies to the nuclear hormone receptor protein family available.
-
Estrogen Receptor-like Molecules
- Androgen R/NR3C4
- Androgen Receptor Agonists
- Androgen Receptor Antagonists
- Additional Androgen Receptor Products
- DAX1/NR0B1
- ER alpha/NR3A1
- ER beta/NR3A2
- ERR alpha/NR3B1
- ERR beta/NR3B2
- ERR gamma/NR3B3
- Estradiol
- Estrogen and Related Receptor Agonists
- Estrogen and Related Receptor Antagonists
- Estrogen and Related Receptor Inhibitors
- Estrogen and Related Receptor Modulators
- Additional Estrogen and Related Receptor Compounds
- Glucocorticoid Receptor Agonists
- Glucocorticoid Receptor Antagonists
- Glucocorticoid Receptor Compounds
- GR/NR3C1
- Mineralocorticoid R/NR3C2
- Mineralocorticoid Receptor Agonists
- Mineralocorticoid Receptor Antagonists
- Progesterone
- Progesterone R/NR3C3
- Progesterone R B/NR3C3
- Progesterone Receptor Agonists
- Progesterone Receptor Antagonists
- TR2/NR2C1
- TR4/NR2C2
-
Retinoic Acid-Related Orphan Receptors
-
Steroid Hormone Metabolism Enzymes
- 11 beta-HSD Inhibitors
- 11 beta-HSD1
- 11 beta-HSD2
- 17 beta-HSD1/HSD17B1
- 17 beta-HSD14/HSD17B14
- Aldo-keto Reductase 1C1/AKR1C1
- Aldo-keto Reductase 1C3/AKR1C3
- Aldo-keto Reductase 1C4/AKR1C4
- CYP3A4
- CYP7A1
- Cytochrome P450 Inhibitors
- Cytochrome P450 Substrates
- Cytosolic Sulfotransferase 1A3/SULT1A3
- Cytosolic Sulfotransferase 1B1/SULT1B1
- Cytosolic Sulfotransferase 1E1/SULT1E1
- Cytosolic Sulfotransferase 2A1/SULT2A1
-
Steroid Hormone Receptor Regulators
-
Thyroid Hormone Receptor-like Molecules
- CAR/NR1I3
- FXR/NR1H4
- LXR alpha/NR1H3
- LXR beta/NR1H2
- LXR-like Receptor Agonists
- LXR-like Receptor Antagonists
- PPAR alpha/NR1C1
- PPAR alpha Receptor Agonists
- PPAR alpha Receptor Antagonists
- PPAR gamma/NR1C3
- PPAR delta/NR1C2
- PPAR delta Receptor Agonists
- PPAR delta Receptor Antagonists
- PPAR gamma Receptor Agonists
- PPAR gamma Receptor Antagonists
- Additional PPAR gamma Receptor Products
- Non-selective PPAR Receptor Agonists
- Pregnane X Receptor Activators
- Pregnane X Receptor Agonists
- PXR/NR1I2
- TLX/NR2E1
- TR alpha/NR1A1
- TR beta 1/NR1A2
- VDR/NR1I1
- Vitamin D3
-
Other Steroid Receptors
- AHR
- Aryl Hydrocarbon Receptor Agonists
- Aryl Hydrocarbon Receptor Antagonists
- Aryl Hydrocarbon Receptor Compounds
- Aryl Hydrocarbon Receptor Ligands
- COUP-TF I/NR2F1
- COUP-TF II/NR2F2
- EAR2/NR2F6
- GCNF/NR6A1
- HNF-4 alpha/NR2A1
- HNF-4 gamma/NR2A2
- LRH-1/NR5A2
- NGFI-B alpha/Nur77/NR4A1
- NGFI-B gamma/NOR-1/NR4A3
- Nurr1/NGFI-B beta/NR4A2
- PNR/NR2E3
- Rev-erb A alpha/NR1D1
- Rev-erb beta/NR1D2
- SF-1/NR5A1
- SHP/NR0B2